Podcasts about life sciences

In this episode of Tiny Show and Tell Us, we talk about breathing in birds — how it takes two breath cycles for air to leave their bodies, and while it travels within their bodies, it's stored in various sacks, some of which are in their butts. Then we discuss how food waste contributes to approximately 8% of global greenhouse gas emissions every year, and what we can do to reduce it. We need your stories — they're what make these bonus episodes possible! Write in to tinymatters@acs.org *or fill out this form* with your favorite science fact or science news story for a chance to be featured.A transcript and references for this episode can be found at acs.org/tinymatters.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

As the lead wreaks havoc on Cooper's development, Shannon searches for answers. Desperate to get a handle on what was happening to her son, she grabs onto a lifeboat - nursing school. Andy tries to piece together the past to make sense of the present.LEAD how this story ends is up to us is a true story written and produced by Shannon Burkett. Co-produced by Jenny Maguire. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper BurkettEP2 features Keith Nobbs and Frank Wood. Music by Peter Salett. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes. Casting by Alaine Alldaffer and Lisa Donadio.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Today's guest is Dr. Steffen Hoffmann, Managing Director of Bosch UK. Dr. Hoffmann joins Emerj Editorial Director Matthew DeMello to explore the strategic deployment of AI across industrial sectors, from manufacturing operations to internal business systems. Dr. Hoffmann shares how AI is helping manufacturers address upstream process variables to reduce defect rates and improve efficiency. He also discusses the importance of “human in the loop” oversight in regulated environments, and how Bosch's internal deployment of generative AI — starting with an HR assistant — serves as a model for cautious, business-aligned innovation. The conversation explores industrial applications of AI governance, the role of internal use cases in de-risking new technologies, and the broader cultural conversation around balancing AI's risks and rewards. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the ‘AI in Business' podcast! If you've enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

Predictable hiring isn't just possible —it's essential. On this episode, host Ryan Dull is joined by Michael Peterson, Sr. Director of Global Talent Acquisition – Talent Sourcing, Intelligence and Innovation at Edwards Lifesciences, to explore how strategic planning, data-driven practices and a consumer-minded approach are shaping modern TA functions in highly regulated industries. Michael walks through his path from aspiring pilot to TA leadership, sharing lessons from roles across healthcare, tech and international organizations. From building teams from scratch to redefining success metrics, Michael also offers practical insights into the evolving TA landscape.Key Takeaways:(00.00) Introduction.(02:35) Michael pivoted from aviation to a career in TA leadership.(04:48) Edwards Lifesciences leads in heart valves, with 17 on Michael's TA team.(05:59) Intelligence and innovation functions are early, with one analytics role in place.(07:58) The Valencia plant proves the strategy works and uncovers key process gaps.(10:11) TA taught the business the market's tough — now it's about how to act on it.(12:52) Quality of hire is the top priority, even if measurement still needs work.(15:12) TA priorities include field roles, tech optimization and guiding AI innovation.(17:01) Focus on doing the right thing, not on being liked.Resources Mentioned:Michael Petersonhttps://www.linkedin.com/in/taleadermichaelkpeterson/Edwards Lifesciences | LinkedInhttps://www.linkedin.com/company/edwards-lifesciences/Edwards Lifesciences | Websitehttps://www.edwards.com/This episode is brought to you by Sagemark HR.Sagemark HR can help you:✔ Improve your talent practices and make better, more informed people decisions.After 20+ years of experience leading Recruiting and Talent Acquisition across a wide variety of industries, I've seen enough hires (over 100,000 to date) to know that hiring decisions truly can make or break an organization.✔ Identify opportunities to not only improve your talent practices, but also delivering tangible business results.We understand every organization is different, and there's no one-size-fits-all magic solution. So we listen first and identify the gaps and sticking points in your current process before ever recommending a solution.✔ Bridge the gap from “traditional” to modern recruiting, without the painful learning curve.We believe recruiting, talent, and HR technology is a deep well of untapped business potential, and our mission is to help you identify and implement those hiring tools in a way that works for you.If you're interested in learning more, you can reach me at:www.sagemarkhr.com✉ ryan.dull@sagemarkhr.com#Talent #Recruiters #Recruiting #HRTech

The FDA has begun urging manufacturers to treat cybersecurity risk management as a material business concern. Hal Porter, Director of Consulting Services, Clearwater, speaks with Allyson Maur, Associate, McGuireWoods, about the implications of the FDA's growing focus on cybersecurity as a core component of medical device safety and financial risk and what that shift means for legal, compliance, and risk professionals. They discuss how manufacturers and providers should navigate these expectations, how legal teams can prepare for regulatory scrutiny, and how cyber risk in the device ecosystem is quickly becoming a board-level issue. Sponsored by Clearwater.Watch this episode: https://www.youtube.com/watch?v=3Y9R5kwRqeULearn more about Clearwater: https://clearwatersecurity.com/ Essential Legal Updates, Now in Audio AHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Premium members. Get all your health law news from the major media outlets on this podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast. Stay At the Forefront of Health Legal Education Learn more about AHLA and the educational resources available to the health law community at https://www.americanhealthlaw.org/.

Medicine stands at the threshold of a new era, where artificial intelligence and systems biology are working hand in hand to make care more personal, predictive, and precise than ever before. AI is already improving diagnostic accuracy, automating administrative tasks, and uncovering patterns in data—like retinal scans or genomics—that humans often miss. Rather than replacing doctors, AI enhances their ability to deliver more informed, precise, and efficient care. At the same time, individuals are gaining tools—from at-home diagnostics to wearable biosensors—that empower them to track and optimize their own health. This shift marks a move from reactive, disease-centered care to a proactive, data-driven model of scientific wellness. In this episode, I talk with Dr. Eric Topol, Dr. Nathan Price, Dr. Leroy Hood, Dr. Vijay Pande, and Daisy Wolf about how artificial intelligence, personalized data, and wearable technology are converging to radically transform medicine. Dr. Eric Topol is Executive Vice President of Scripps Research and founder/director of its Translational Institute, recognized as one of the top 10 most cited researchers in medicine with over 1,300 publications. A cardiologist and author of several bestselling books on the future of medicine, he leads major NIH grants in precision medicine and shares cutting-edge biomedical insights through his Ground Truths newsletter and podcast. Dr. Nathan Price is Chief Scientific Officer at Thorne HealthTech, author of The Age of Scientific Wellness, and a National Academy of Medicine Emerging Leader. He also serves on the Board on Life Sciences for the National Academies and is Affiliate Faculty in Bioengineering and Computer Science at the University of Washington. Dr. Leroy Hood is CEO and founder of Phenome Health, leading the Human Phenome Initiative to sequence and track the health of one million people over 10 years. A pioneer in systems biology and co-founder of 17 biotech companies, he is a recipient of the Lasker Prize, Kyoto Prize, and National Medal of Science. Dr. Vijay Pande is a General Partner at Andreessen Horowitz and founder of a16z Bio + Health, managing over $3 billion in life sciences and healthcare investments at the intersection of biology and AI. An Adjunct Professor at Stanford, he is known for his work in computational science, earning honors like the DeLano Prize and a Guinness World Record for Folding@Home. Daisy Wolf is an investing partner at Andreessen Horowitz, specializing in healthcare AI, consumer health, and healthcare-fintech innovation. She previously worked at Meta and in various startups, holds a JD from Yale Law, an MBA from Stanford, and a BA from Yale, and is based in New York City. This episode is brought to you by BIOptimizers. Head to bioptimizers.com/hyman and use code HYMAN10 to save 10%. Full-length episodes can be found here: Can AI Fix Our Health and Our Healthcare System? The Next Revolution In Medicine: Scientific Wellness, AI And Disease Reversal The Future of Healthcare: The Role of AI and Technology

Structural heart innovation is rewriting the future of cardiovascular care—delivering faster recoveries, better outcomes, and a new standard of precision through less invasive procedures. Breakthroughs in imaging, smarter device design, and real-time data are empowering doctors to tackle even the most complex heart conditions with unmatched accuracy. Leading this heart-health revolution is Edwards Lifesciences, a global pioneer changing the way the world treats cardiovascular disease. CEO Bernard Zovighian goes Inside the ICE House to discuss how, under his leadership, the company is breaking boundaries and saving lives - pne innovation at a time.

Aligning Culture, Talent & Strategy for Scalable Growth with Dr. Kallol Biswas, Ph.D. In this powerful episode of The Hurricane H Show, we sit down with Dr. Kallol Biswas, Ph.D. — a global leadership expert, Principal Consultant, and Fractional Executive with over 20 years of experience leading high-performance teams across pharma, biotech, and medical devices. Together, we explore how organizations can align culture, talent, and business strategy to unlock scalable growth — especially in today's fast-evolving, innovation-driven world. Dr. Biswas shares key insights on transforming technical leaders into strategic influencers, building trust across global teams, and the growing role of fractional leadership in regulated industries. Whether you're a CEO, team leader, HR executive, or an emerging professional in life sciences, this episode will shift how you view leadership, execution, and long-term performance. Topics Covered: Leadership transformation in pharma & biotech Aligning culture with strategy and execution Fractional executive insights Scaling high-performance teams globally The future of life sciences leadership

Aligning Culture, Talent & Strategy for Scalable Growth with Dr. Kallol Biswas, Ph.D. In this powerful episode of The Hurricane H Show, we sit down with Dr. Kallol Biswas, Ph.D. — a global leadership expert, Principal Consultant, and Fractional Executive with over 20 years of experience leading high-performance teams across pharma, biotech, and medical devices. Together, we explore how organizations can align culture, talent, and business strategy to unlock scalable growth — especially in today's fast-evolving, innovation-driven world. Dr. Biswas shares key insights on transforming technical leaders into strategic influencers, building trust across global teams, and the growing role of fractional leadership in regulated industries. Whether you're a CEO, team leader, HR executive, or an emerging professional in life sciences, this episode will shift how you view leadership, execution, and long-term performance. Topics Covered: Leadership transformation in pharma & biotech Aligning culture with strategy and execution Fractional executive insights Scaling high-performance teams globally The future of life sciences leadership

John Maytham chats to Dr Rosa Busquets from Kingston University, School of Life Sciences, Pharmacy and Chemistry, about microplastics in human blood, and procedures that claim to be able to remove them. Presenter John Maytham is an actor and author-turned-talk radio veteran and seasoned journalist. His show serves a round-up of local and international news coupled with the latest in business, sport, traffic and weather. The host’s eclectic interests mean the program often surprises the audience with intriguing book reviews and inspiring interviews profiling artists. A daily highlight is Rapid Fire, just after 5:30pm. CapeTalk fans call in, to stump the presenter with their general knowledge questions. Another firm favourite is the humorous Thursday crossing with award-winning journalist Rebecca Davis, called “Plan B”. Thank you for listening to a podcast from Afternoon Drive with John Maytham Listen live on Primedia+ weekdays from 15:00 and 18:00 (SA Time) to Afternoon Drive with John Maytham broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/BSFy4Cn or find all the catch-up podcasts here https://buff.ly/n8nWt4x Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567See omnystudio.com/listener for privacy information.

When it comes to artificial intelligence, the tables are turning and there is a shift in considering it a hype to understanding that AI is a real necessity. And 2025 is becoming a turning point wherein practical, embedded AI begins to scale. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Florian Schnappauf, VP, enterprise commercial strategy Europe, at Veeva Systems. The conversation covers commercial model evolution, precision engagement, the importance of quality data in a personalisation strategy, and – of course – compliance. You can also listen to episode 197a of the pharmaphorum podcast in the player below, download the episode to your computer, or find it - and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from.

3,500 years ago, cats started showing up in Egyptian paintings on tomb walls and in sculptures and carvings. Not only were they abundant in these representations, but it was very clear that they were domestic. They had collars around their necks and were eating out of food dishes underneath the dining room table. That scene is not so different from the life many cats lead today. So how did cats go from the wild to being immortalized on tomb wall paintings and lounging on living room couches? And just how domestic is a domestic cat?Send us your science facts, news, or other stories for a chance to be featured on an upcoming Tiny Show and Tell Us bonus episode. And, while you're at it, subscribe to our newsletter!Links to the Tiny Show and Tell stories are here and here. All Tiny Matters transcripts and references are available here.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode of The Dish on Health IT, Tony Schueth and Rob Dribbon are joined by Neikisha Charles Director of Quality Improvement and Risk Management of Bedford Stuyvesant Family Health Center (Bed-Stuy), a federally qualified health center (FQHC) in Brooklyn, NY. Together, they dig into common misconceptions about FQHCs and shine a spotlight on the opportunities they present for strategic engagement across the healthcare ecosystem—especially for health IT and life sciences organizations.Neikisha opens with her personal journey: starting as a data analyst at Bed-Stuy in 2021 and quickly rising into her current leadership role because of her knack for using data to drive quality improvement. Her story illustrates the increasing sophistication of FQHCs and sets the tone for a broader conversation about how these organizations are evolving.To help orient listeners who may not fully understand the role of FQHCs, Neikisha provides a clear definition: FQHCs are federally funded community-based providers mandated to offer care to all residents in underserved areas, regardless of insurance status. They are deeply attuned to social determinants of health and committed to removing access barriers for vulnerable populations.Rob adds context from his years in pharma, highlighting the unique value proposition of FQHCs—namely, their holistic and integrated approach to care. He urges listeners not to overlook these organizations simply because they've historically focused on commercial health systems.Neikisha then debunks a major myth: that FQHCs only serve uninsured or homeless patients. In fact, Bed-Stuy primarily serves Medicaid-managed populations, but also sees commercially insured and uninsured individuals, offering services on a sliding scale. Services range from primary care and mental health to dental, podiatry, and optometry, along with extensive care coordination and social support services.When asked what health IT vendors and life sciences companies may be missing, Neikisha makes it clear: FQHCs are not tech or data-poor. Bed-Stuy uses a robust EHR (eClinicalWorks), the Azara DRVS population health platform, and Artera for two-way patient communication. These tools aren't just window dressing—they are integrated into care delivery to close gaps, improve compliance, and monitor population health in real time.She offers a compelling case study: When colorectal cancer screening rates began to drop, Neikisha led a data-driven campaign using Azara to identify noncompliant patients, Artera to send targeted outreach texts, and a partnership with Exact Sciences to offer Cologuard kits to patients by mail. The result? A 12.3% increase in screening compliance over 18 months.Rob underscores the significance of this approach—not just the smart use of technology, but also the community-level relationships and the trust that make this kind of intervention effective.The discussion then shifts to interoperability. Neikisha notes the complexities of data exchange and the importance of dedicated roles like a Director of Health Integration to manage relationships and reporting. Bed-Stuy is connected to a regional health information organization (RHIO), uses platforms like Azara to track transitions of care, and maintains read-only EMR access with key partners to streamline care coordination. While true vendor-agnostic interoperability remains elusive, FQHCs are actively working with what's available.Tony brings the conversation back to the bigger picture: What gaps do vendors and life sciences partners need to close? Neikisha points to the need for better education about what FQHCs actually do and who they serve. She challenges companies to co-create solutions with FQHCs—offering tools that reflect real-world workflows and support sustainable partnerships rather than transactional engagements.The episode wraps with both Rob and Neikisha emphasizing the untapped potential of FQHCs. With over 30 million Americans relying on them for care, these organizations are not fringe players—they are essential infrastructure. And as Neikisha puts it, they're “here to stay.” To partner successfully, the first step is simple: reach out, learn what's needed, and build something meaningful together.Related ContentWhat Are FQHCs, & Should Life Sciences Manufacturers Even Care About Them?HIT Perspectives May 2025: FQHC Myth vs Fact Bedford Stuyvesant Family Health Center Brooklyn NY - Primary Care Services 

A mysterious dust fills a young family's apartment. The truth begins to unravel when the mother gets a call from the pediatrician - the monster deep within the walls has been unleashed. LEAD how this story ends is up to us is a true story written and produced by Shannon Burkett. Co-produced by Jenny Maguire. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper Burkett. EP1 features Zak Orth, Jenny Maguire, Daphne Gaines, and Micheal Gaston. Music by Peter Salett. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes. Casting by Alaine Alldaffer and Lisa Donadio.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Engineering has always been about solving problems—but today's problems are bigger, greener, and more complex than ever before. From cutting carbon in concrete to tunnelling under major cities, the pressure is on to build infrastructure that's not just strong, but sustainable.In this episode, we explore what it really takes to deliver major engineering projects while meeting ambitious climate targets. We'll hear how to lead under pressure, manage high-stakes decisions, and unlock career-defining opportunities through mentorship and curiosity. Plus, we look at how engineers can drive innovation from within—by asking the right questions, building strong teams, and embracing failure as a pathway to growth.Our guest brings over 20 years of hands-on experience across some of the UK and Ireland's biggest civil infrastructure projects, including Crossrail, the Limerick Tunnel, and the Luas Cross City. He's passionate about decarbonising construction and shaping the next generation of engineering leaders. It's a pleasure to welcome Ross Cullen, Group Chief Engineer and Head of Engineering Services at Sisk.THINGS WE SPOKE ABOUTThe importance of people skills in the engineering industryThe challenges in working on engineering projects underground and underwaterHow sustainability and decarbonisation play a role in engineering todayThe need for innovation and continuous improvement in an ever evolving industryCareer development and ownership, and the importance of being inquisitive.GUEST DETAILSRoss Cullen is Group Chief Engineer and Head of Engineering Services at Sisk. He is responsible for developing and leading Engineering strategy for the organisation supporting pre-construction and current projects under construction across Ireland, the UK and Europe. In 2018, Ross established an Engineering Services department in Sisk, growing a business out of the Civil Engineering unit and created an internal consultancy to provide construction engineering consultancy services to the wider GroupRoss is a Chartered Civil Engineer and Fellow of Engineers Ireland and the Institute of Civil Engineers. His background extends from working on complex infrastructure schemes, where he has been central to the design management process. His experience extends across multiple sectors including Infrastructure, Civil Engineering, Marine, Data, Energy, Life Sciences, Commercial and Residential.Ross is passionate about sustainability and seeking out carbon savings in the construction industry. Ross is chair of the Sisk Low Carbon Concrete working group and is actively involved in several collaborations with industry and academic institutes to support the development of new low carbon concrete solutions.MORE INFORMATIONLooking for ways to explore or advance a career in the field of engineering? Visit Engineers Ireland to learn more about the many programs and resources on offer. https://www.engineersireland.ie/   Engineers Journal AMPLIFIED is produced by DustPod.io for Engineers Ireland.QUOTESBe inquisitive, ask questions, because people are incredibly generous with their time if you ask the questions and you show an interest.  - Ross CullenYou need to take some ownership for your own career. You need to decide fairly early what you like, what you don't like, because it's important to rule out certain things. - Ross CullenYou learn from problems. You learn from what's caused you pain. You don't learn from what goes well - Ross CullenComing up with a good idea is the easy bit with anything… sometimes making it better isn't the right thing to do. - Ross CullenConstruction is a people business, and that's what makes it exciting. You meet different people, different skill sets, extremely diverse. - Ross Cullen

“Saturday Mornings Show” host Glenn van Zutphen and co-host Neil Humphreys speak to Grant Abel, Assistant Vice-President of Life Sciences at Singapore Oceanarium at Resorts World Sentosa’s revamped and leading ocean institute, to inspire greater knowledge, love, and action for the ocean and aquatic life.See omnystudio.com/listener for privacy information.

Tune in as Glenn Hunzinger, PwC's Health Industries Leader, sits down with Nicole Montgomery, Shannon O'Shea, and Phil Sclafani to unpack the sweeping implications of the newly signed One Big Beautiful Bill Act (OBBBA). With nearly a third of the bill dedicated to healthcare, the team explores how this landmark legislation will reshape coverage, funding, and delivery across the payer, provider, and pharma landscape.Discussion highlights:The OBBBA introduces new work requirements and eligibility rules that could lead to coverage loss for over 13 million people, placing new burdens on payers and statesProviders face increased uncompensated care, especially in rural areas, with added administrative complexity and a push toward technology and alternative care modelsPayers are bracing for membership loss, reduced Medicaid funding, and increased administrative load as new eligibility rules take effectPharma may see reduced demand from public programs but gains through an orphan drug exemption and incentives for domestic manufacturingThe bill's sweeping changes will disrupt healthcare, but with foresight, organizations can model financial impact, prepare for operational disruption, and plan strategic responsesSpeakers:Glenn Hunzinger (host), Health Industries Leader, PwCShannon O'Shea, Principal, Health Transformation, Provider Clinical Transformation, PwCPhil Scalfani, Principal, Customer Transformation, Pharmaceutical & Life Sciences, PwCNichole Montgomery, Principal, Health Transformation, Health Services, PwCLinked Materials:https://www.pwc.com/us/en/industries/health-industries/library/impact-of-obbba-on-us-health-system.html https://www.pwc.com/us/en/industries/health-industries/health-policy-and-intelligence-institute.htmlFor more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

Brian Dean Abramson, Adjunct Professor of Vaccine Law, Florida International University College of Law and University of Houston Law Center, speaks with Vanessa Burrows, Partner, Simpson Thacher & Bartlett LLP, and Dr. René Najera, Director of Public Health, College of Physicians of Philadelphia, about the rapidly changing environment of vaccine law and regulation. They discuss current availability, recommendations, and funding of vaccines at the federal level; implications for companies involved in vaccine testing, development, distribution, and administration; the future of employer mandates; changes at the state level; and developments related to the National Vaccine Injury Compensation Program. Brian is the author of AHLA's Vaccine, Vaccination, and Immunization Law, Third Edition.Watch this episode: https://www.youtube.com/watch?v=PLaXvbvZ7cQLearn more about the book: https://store.lexisnexis.com/ahla/products/ahla-vaccine-vaccination-and-immunization-law-ahla-members-grpussku5628107m.htmlEssential Legal Updates, Now in Audio AHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Premium members. Get all your health law news from the major media outlets on this podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast. Stay At the Forefront of Health Legal Education Learn more about AHLA and the educational resources available to the health law community at https://www.americanhealthlaw.org/.

The life sciences industry is projected to need thousands more workers over the next decade. Microcredentials are the newest way some educators and business leaders are looking to fill in-demand jobs that require specialized skills.

In this episode of Tiny Show and Tell Us, we tackle the debate surrounding whether or not it rains diamonds on Saturn. Then we talk about how UV degradation can break down some of the harmful residual dyes from plastic pollution, and what it means in the context of microplastics. We need your stories — they're what make these bonus episodes possible! Write in to tinymatters@acs.org *or fill out this form* with your favorite science fact or science news story for a chance to be featured.A transcript and references for this episode can be found at acs.org/tinymatters.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Lexi Silver is 15 years old. She lost both of her parents before she turned 11. That should tell you enough—but it doesn't. Because Lexi isn't here for your pity. She's not a sob story. She's not a trauma statistic. She's a writer, an advocate, and one of the most emotionally intelligent people you'll ever hear speak into a microphone.In this episode, Lexi breaks down what grief actually feels like when you're a kid and the adults around you just don't get it. She talks about losing her mom on Christmas morning, her dad nine months later, how the system let her down, and how Instagram trolls tell her she's faking it for attention. She also explains why she writes, what Experience Camps gave her, how she channels anger into poems, and what to say—and not say—to someone grieving.Her life isn't a Netflix drama. But it should be.And by the way, she's not “so strong.” She's just human. You'll never forget this conversation.RELATED LINKS• Lexi on Instagram: @meet.my.grief• Buy her book: The Girl Behind Grief's Shadow• Experience CampsFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dr. George Sledge, Executive VP and Chief Medical Officer of Caris Life Sciences, is using advanced molecular testing, including DNA, RNA, and protein analysis, to identify specific mutations and characteristics of a patient's tumor, allowing for more personalized and targeted treatment. The company is developing liquid biopsies to detect cancer early, identify minimal residual disease, and assess the potential for future cancer development. Caris has a database of over half a million patients whose tumors have undergone next-generation sequencing, allowing them to draw increasingly accurate conclusions. The future of precision oncology is expected to involve broader and earlier use of next-generation sequencing as the cost of the test continues to decrease significantly. George explains, "Caris Life Sciences is a molecular diagnostics company. Patients and their physicians send us tumor samples that can be obtained either from the primary tissue or from a distant recurrent site. When they come to us, we do several things. We look at DNA, what's called whole exome. We look at RNA, what's called whole transcriptome. We also frequently look at the protein level at immunohistochemistry, looking at slides that have been stained to look for particular molecular lesions that may be important from a treatment standpoint. Based on all of these, we're able to provide patients with information about which drugs represent the most appropriate treatment for their disease. This, of course, allows you to go to a drug that hopefully will be less toxic and more effective for your particular disease."  "When we look at the very specific mutations that manifest themselves at the level of either DNA or RNA, this requires fairly high technology, what's called next-generation sequencing, which allows us to pick up all these individual mutations that make up a particular patient's cancer. And every patient's cancer is different. Every patient's cancer involves different combinations of mutations that result in different responses to different treatments." #CarisLifeSciences #CancerResearch #PrecisionMedicine #RealWorldData #AccestoCare #HealthEquity #NextGenerationSequencing #NGS #LiquidBiopsy #ClinicoGenomic #Biomarkers #PanCancer carislifesciences.com Listen to the podcast here

Dr. George Sledge, Executive VP and Chief Medical Officer of Caris Life Sciences, is using advanced molecular testing, including DNA, RNA, and protein analysis, to identify specific mutations and characteristics of a patient's tumor, allowing for more personalized and targeted treatment. The company is developing liquid biopsies to detect cancer early, identify minimal residual disease, and assess the potential for future cancer development. Caris has a database of over half a million patients whose tumors have undergone next-generation sequencing, allowing them to draw increasingly accurate conclusions. The future of precision oncology is expected to involve broader and earlier use of next-generation sequencing as the cost of the test continues to decrease significantly. George explains, "Caris Life Sciences is a molecular diagnostics company. Patients and their physicians send us tumor samples that can be obtained either from the primary tissue or from a distant recurrent site. When they come to us, we do several things. We look at DNA, what's called whole exome. We look at RNA, what's called whole transcriptome. We also frequently look at the protein level at immunohistochemistry, looking at slides that have been stained to look for particular molecular lesions that may be important from a treatment standpoint. Based on all of these, we're able to provide patients with information about which drugs represent the most appropriate treatment for their disease. This, of course, allows you to go to a drug that hopefully will be less toxic and more effective for your particular disease."  "When we look at the very specific mutations that manifest themselves at the level of either DNA or RNA, this requires fairly high technology, what's called next-generation sequencing, which allows us to pick up all these individual mutations that make up a particular patient's cancer. And every patient's cancer is different. Every patient's cancer involves different combinations of mutations that result in different responses to different treatments." #CarisLifeSciences #CancerResearch #PrecisionMedicine #RealWorldData #AccestoCare #HealthEquity #NextGenerationSequencing #NGS #LiquidBiopsy #ClinicoGenomic #Biomarkers #PanCancer carislifesciences.com Download the transcript here

This week on The Jira Life, we're joined by Rina Nir — CEO of RadBee, Atlassian expert, and specialist in helping life sciences teams streamline their SDLC while staying compliant.We'll dive into how regulated industries like medical devices and biotech are using Atlassian tools (Jira, Confluence, and Marketplace apps) to build better, safer products — without getting buried in validation and documentation chaos.If you work in a regulated industry, are navigating software compliance, or are curious about how AI fits into this equation — you won't want to miss this conversation.What Rina is currently up to:- Signup for SDLC Summer Series:https://lnkd.in/e_HZDCiM- Snapshots Landingpage:https://lnkd.in/eb_TdYJt- Marketplace listing:https://lnkd.in/ee_BmxiFThank you to Revyz for backing us up and making The Jira Life possible. https://www.revyz.io/The Jira Life=====================================Having trouble keeping up with when we are live? Sign up for our Atlassian Community Group!https://lnkd.in/g5834KixOr Follow us on LinkedIn!https://lnkd.in/epszdbRjBecome a member on YouTube to get access to perks:https://lnkd.in/gzDWDAzNHosts:- Alex "Dr. Jira" Ortizhttps://lnkd.in/eP2TQHcEhttps://lnkd.in/ewxmQs2s- Rodney "The Jira Guy" Nissenhttps://lnkd.in/exhJAMVmhttps://thejiraguy.com- Sarah Wrighthttps://lnkd.in/ejT5ZAFR Producer:- "King Bob" Robert Wenhttps://lnkd.in/eDEJxdt6Executive Producer: - Lina OrtizMusic provided by Monstercat:=====================================Intro: Nitro Fun - Cheat Codeshttps://lnkd.in/eZp7w7ieOutro: Fractal - Atriumhttps://lnkd.in/eMpcN8rf

Host Gil Bashe welcomes Sally Ann Frank the Microsoft for Startups Mentor of Microsoft. She is the global leader for health and life sciences at Microsoft for Startups, responsible for strategy, programs, and portfolio, accelerating the development of innovative, market-making companies. With more than 25 years of experience in high-tech business development, sales, and marketing, she is passionate about helping health and life sciences companies and startups use Microsoft technology to provide better, more-cost effective care. As the WW Lead for Health & Life Sciences at Microsoft for Startups, she work directly with founders, VCs, M12 and others in the industry to partner with Microsoft and accelerate their development and growth. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Paris Panayiotopoulos, Senior Managing Director at Blackstone Life Sciences, shares how the firm's broad life sciences strategy has been advancing innovation across the life sciences ecosystem in three key ways: late-stage product financing (Collaboration) and new company creation (Ownership), and non-dilutive financing (Credit and Royalties). He explains how Blackstone is bridging the innovation funding gap through high-conviction partnerships with larger BioPharma and MedTech companies, and targeted investment in late-stage trials.

In this episode of The Pet Food Science Podcast Show, Dr. Sara Cutler from Kemin Nutrisurance discusses the complexities of determining the shelf life of pet food products. She explains how pet food manufacturers assess shelf life, including factors such as ingredient stability, oxidation, and packaging. Dr. Cutler also shares insights on how different pet food formats, like kibble, wet, and freeze-dried, pose unique challenges to shelf life. Tune in to learn about the science behind keeping pet food fresh and nutritious. Listen now on all major platforms!"Shelf life in pet food is determined by how long a product maintains its quality and nutritional value over time."Meet the guest: Dr. Sara Cutler is the Senior Technical Service Manager at Kemin Nutrisurance, specializing in pet food safety and shelf life management. She holds a Ph.D. from Iowa State University in Animal Health and has over 17 years of experience in the pet food industry. Dr. Cutler has dedicated much of her career to studying how ingredient quality impacts the shelf life and nutritional integrity of pet food products. Liked this one? Don't stop now — Here's what we think you'll love!Dr. Jackie Parr: Tailoring Pet Diets | Ep. 101Louise Calderwood: Modernized Pet Food Labels | Ep. 80Dr. George Fahey: Pet Nutrition & Fiber | Ep. 75What will you learn:(00:00) Highlight(01:00) Introduction(05:00) What is shelf life?(08:15) Oxidation and testing methods(13:00) Importance of sensory attributes(18:00) Challenges with packaging(22:20) Fresh and frozen pet food(35:45) Final QuestionsThe Pet Food Science Podcast Show is trusted and supported by innovative companies like:* Kemin* Trouw Nutrition- Wilbur-Ellis Nutrition- Biorigin- Scoular

On May 7, 1981, influential physicist Richard Feynman gave a keynote speech at Caltech. Feynman opened his talk by politely rejecting the very notion of a keynote speech, instead saying that he had his own ideas on what to discuss and that everyone should speak on what they please. And for Feynman, this meant proposing a new technology that could simulate physics with computers. That lecture 44 years ago is widely considered to have kicked off the field of quantum computing. In today's episode we dive into the world of quantum computing — its big challenges and exciting potential applications such as decoding tough-to-crack encrypted messages or discovering new drugs. Send us your science facts, news, or other stories for a chance to be featured on an upcoming Tiny Show and Tell Us bonus episode. And, while you're at it, subscribe to our newsletter!Links to the Tiny Show and Tell stories are here and here. All Tiny Matters transcripts and references are available here.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, I sit down with two early-career researchers and open science advocates: Harini Lakshmi Narayanan, a postdoctoral researcher in cancer diagnostics at University Hospital Zurich, and Madita Determann, a postdoc studying liver-related diseases who began her career as a surgical assistant in Germany.Both are leaders in OILS (Open Innovation in Life Sciences), a volunteer-run organization that promotes transparency, reproducibility, and collaboration in scientific research. They share how navigating risky career conversations—like negotiating time for unpaid passion projects or walking away from stable jobs to pursue higher education—helped them step into more aligned, impactful roles.We explore what open science really means (spoiler: it's not yet the default), why reproducible research matters for public health and innovation, and how community-driven efforts like OILS are equipping early-career scientists with tools, confidence, and global connections.Key takeaways for ambitious women in STEM and leadership:Self-advocacy is a service—especially when it aligns you with purpose-driven work.“Brazen audacity” is sometimes necessary (and underrated).Open, inclusive spaces fuel innovation—and your voice matters in shaping them.Bonus: Harini and Madita also reveal their favorite hiking spots in the Swiss Alps.

In this episode of The Poultry Nutrition Blackbelt Podcast, Dr. Birger Svihus from the Norwegian University of Life Sciences breaks down how particle size affects broiler feeding behavior. He shares insights into how birds select feed particles, their preferences for fines, and the implications for feed formulation. Find out how a closer look at pecking patterns could change the way we think about poultry nutrition. Listen now on all major platforms!"The bird is pecking more than once per second. So it's an extremely rapid rate of pecking."Meet the guest: Dr. Birger Svihus earned his Ph.D. in Poultry Nutrition from the Agricultural University of Norway, where he currently serves as a professor at the Norwegian University of Life Sciences. His work focuses on cereal fiber, starch, feed structure, and digestive function in poultry. He's published extensively and leads nutrition research across Europe.Liked this one? Don't stop now — Here's what we think you'll love!What you'll learn:(00:00) Highlight(01:13) Introduction(02:24) Particle size impact(03:33) Feeding behavior science(06:03) Beak capacity limits(08:48) Preference for fines(09:57) Size vs. nutrient delivery(11:26) Closing thoughtsThe Poultry Nutrition Blackbelt Podcast is trusted and supported by innovative companies like:* Kerry* Kemin- BASF- Poultry Science Association- Anitox

Michelle Andrews built a career inside the pharma machine long before anyone knew what “DTC” meant. She helped launch Rituxan and watched Allegra commercials teach America how to ask for pills by name. Then she landed in the cancer fun house herself, stage 4 breast cancer, and learned exactly how hollow all the “journey” slide decks feel when you're the one circling the drain.We talk about what happens when the insider becomes the customer, why pill organizers and wheat field brochures still piss her off, and how she fired doctors who couldn't handle her will to live. You'll hear about the dawn of pharma advertising, the pre-Google advocacy hustle, and what she wants every brand team to finally admit about patient experience.If you've ever wondered who decided windsurfing was the best way to sell allergy meds—or what happens when you stop caring if you make people uncomfortable—listen up.RELATED LINKSMichelle Andrews on LinkedInTrinity Life Sciences – Strategic AdvisoryJade Magazine – Ticking Time Bombs ArticleNIHCM Foundation – Breast Cancer StoryFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Inside INdiana Business Radio for the morning of July 22, 2025. CountryMark is set to cut the ribbon on a $100 million expansion of its operations in Mt. Vernon that will lead to the production of renewable diesel fuel. Indiana gets designated the Radiopharmaceutical Capital of the World. Plus, work begins on an affordable housing project in Loogootee. Get the latest business news from throughout the state at InsideINdianaBusiness.com.

From finding simple recipes to diagnosing complicated illnesses, artificial intelligence (AI) is becoming an increasingly useful part of everyday life, but the space and resources it takes to power that technology is immense and that is hitting close to home for some tribes. The Tonawanda Seneca Nation in New York just filed a lawsuit against a proposed 900,000-square-foot AI data center a mile away from their reservation. Chief Kenith Dale Jonathan says the center would harm air quality, water, and wildlife. We'll hear from the tribe and the potential for data center encroachment elsewhere. We'll also look at how the Trump administration's push to use AI in medicine would benefit or harm Native Americans. GUESTS Christine Abrams (Tonawanda Seneca), office administrator for the Tonawanda Seneca Nation Council of Chiefs Grandell “Bird” Logan (Tonawanda Seneca), media spokesperson for the Tonawanda Seneca Nation Dr. Krystal Tsosie (Diné), assistant professor in the School of Life Sciences at Arizona State University Dr. David Wilson (Diné), associate vice president for health research and professor and chair of Indigenous Health at the University of North Dakota

Send us a textIn this episode of the Life Science Success Podcast, my guest is Ashley Scholz, the Vice President of Marketing at Vector Laboratories, who brings over 16 years of experience in medical devices, diagnostics, and strategic marketing. With a proven track record of driving growth, building high-performing teams, and optimizing commercial strategies, Ashley shares her insights on innovation in the life sciences industry.00:00 Introduction to Life Science Success Podcast00:47 Meet Ashley Scholz: VP of Marketing at Vector Laboratories01:21 Ashley's Career Journey and Experience04:52 Transition to Vector Laboratories06:16 Challenges and Learnings at WL Gore13:10 Building High Performing Teams16:08 Why Vector Labs?21:36 Vector Labs' Mission and Future Focus22:49 Marketing's Role in B2B Transition25:24 Supporting Scientists and Researchers26:35 Innovative Projects and AI Integration29:31 Impact of Recent Acquisitions31:12 Balancing Commercial Growth and Customer-Centricity35:14 Leadership and Organizational Insights38:56 Inspiration and Concerns40:47 Excitement for Future Strategies43:52 Conclusion and Final Thoughts

With external shifts in regulatory uncertainty tied to the IRA, payer pressures, shifting Federal and state policies, and broader scrutiny around pricing, Life Science companies are transforming their operations to deliver better value, grow, and create meaningful impact in the future. In this last episode of the Strategic Transformation series, Mindy McGrath is joined by Karen Baldry and Andrew Sgarlato to discuss what's driving strategic transformations, how life science companies are tackling this and key considerations for leaders embarking on this journey.To learn more about how we can help your team navigate these strategic decisions, reach out to Karen.Baldry@vynamic.com and Andrew.Sgarlato@vynamic.com. Podcast Tags: healthcare, life sciences, healthcare strategy, health innovation, strategic transformation Panel – Mindy McGrath, Karen Baldry, Andrew Sgarlato Research & Production – Mindy McGrath, Karen Baldry, Andrew Sgarlato Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com.

The CISO role is no longer just about protecting IT assets — it's about navigating AI risks, complex regulations, and building digital trust across the enterprise. In an era where digital trust is more important than ever, how do CISOs stay ahead of evolving threats? What impact does AI have on cybersecurity and privacy compliance? And how can organizations empower every employee to contribute to ongoing digital safety? Join cybersecurity expert and former military major Aman Tara in conversation with Punit Bhatia as they explore the evolving responsibilities of CISOs in today's digital landscape. Aman shares why CISOs must think like hackers to stay ahead, how to manage emerging AI threats, and ways to ensure compliance with global data privacy laws. If you want to understand the future of cybersecurity leadership and how to foster trust in an AI-driven era, this episode is a must-watch! KEY CONVERSION 00:01:44 What is Digital Trust for Aman Tara 00:02:44 What role does the CISO play in creating Digital Trust? 00:04:59 How to manage overlap in a CISO role with privacy function 00:06:17 Do you have regular meetings with privacy counterparts? 00:08:19 Impact of AI and emerging technologies on the role of CISO 00:09:58 How Should a CISO respond when using unsafe tools and create risk in organization? 00:12:00 What can everyone do to ensure ongoing digital trust and safety? 00:15:17 Amman's Book and Personal Journey  ABOUT GUEST Aman Tara is an ex-military Major and a qualified attorney. He holds an associate diploma in Software Engineering, a bachelor's degree in Life Sciences and Economics, a degree in Law, and his MBA from Iowa, USA. He is a Certified Information System Auditor, Certified Data Privacy Solutions Engineer, Certified Fraud Examiner, Certified Amazon Web Services Cloud Practitioner and a Scrum Master. He has also done a Cybersecurity course at Massachusetts Institute of Technology (MIT).  After serving in the military for a decade in various combat and staff roles, he moved to the corporate world in 2011. He has worked on IT audits, IT security and Cybersecurity assessments, Third Party Risk Management projects for various Fortune 500 companies across the USA and South Asia. Presently, he is the Executive Director for one of the world's largest banks, working in their Cybersecurity department and Board of Directors of three Non-Profit Organizations based outside of the USA.  He has been featured in articles overseas and invited as speaker for various US based and international seminars. He conducts workshops for corporates on stress management, hosts a live radio show every week in Texas, USA, and has also authored a book ‘Just Did It'.  ABOUT HOST Punit Bhatia is one of the leading privacy experts who works independently and has worked with professionals in over 30 countries. Punit works with business and privacy leaders to create an organization culture with high privacy awareness and compliance as a business priority. Selectively, Punit is open to mentor and coach professionals.  Punit is the author of books “Be Ready for GDPR' which was rated as the best GDPR Book, “AI & Privacy – How to Find Balance”, “Intro To GDPR”, and “Be an Effective DPO”. Punit is a global speaker who has spoken at over 30 global events. Punit is the creator and host of the FIT4PRIVACY Podcast. This podcast has been featured amongst top GDPR and privacy podcasts.  As a person, Punit is an avid thinker and believes in thinking, believing, and acting in line with one's value to have joy in life. He has developed the philosophy named ‘ABC for joy of life' which passionately shares. Punit is based out of Belgium, the heart of Europe.  RESOURCES Websites www.fit4privacy.com,www.punitbhatia.com, https://www.linkedin.com/in/aman-tara-cisa-cdpse-cfe-b6095483/ Podcast https://www.fit4privacy.com/podcast Blog https://www.fit4privacy.com/blog YouTube http://youtube.com/fit4privacy   

In this episode of Tiny Show and Tell Us, we cover squirrel pox — a disease that hasn't had a huge impact in the United States but has decimated populations of squirrels in the UK. Then we talk about the story that Napoleon's army lost the Battle of Waterloo because the military uniforms used tin buttons that broke apart in cold temperatures, making it harder for the troops to survive. But is there any truth to that story? We need your stories — they're what make these bonus episodes possible! Write in to tinymatters@acs.org *or fill out this form* with your favorite science fact or science news story for a chance to be featured.A transcript and references for this episode can be found at acs.org/tinymatters.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

What if the C-suite wasn't the destination—but a stop on the way to something more fulfilling?In this heartfelt episode of Women Leaders on the Move, host Natalie Benamou sits down with Jennifer Peters, a visionary Life Sciences Executive and an author to the upcoming anthology Power of Next: Bold Moves by Design. Jennifer shares her deeply personal journey, one shaped by resilience, reinvention, and the power of saying “yes” to unexpected turns.From starting over in a new city as a single mom to launching a successful business during the 2008 recession, Jennifer reveals how nonlinear paths often lead to the most meaningful destinations. She opens up about navigating ageism, redefining success, and why letting go of titles can be the ultimate power move.✨ In this episode, you'll hear:How to reframe "overqualified" into a leadership strengthWhy embracing change—at any age—can be your greatest advantageA moving story of courage, legacy, and finding silver linings in unexpected moments"I realized I've accomplished more than I thought I did—and I'm proud of the decisions I've made, even the ones that didn't go as planned. There's always a silver lining." – Jennifer PetersWhether you're navigating a career pivot or redefining what's next, Jennifer's story will leave you feeling empowered to make bold moves—by your own design.

Dr. Anne Marie Morse walks into the studio like a one-woman Jersey Broadway show and leaves behind the best damn TED Talk you've never heard. She's a neurologist, sleep medicine doc, narcolepsy expert, founder of D.A.M.M. Good Sleep, and full-time myth buster in a white coat. We talk about why sleep isn't a luxury, why your mattress does matter, and how melatonin is the new Flintstones vitamin with a marketing budget. We unpack the BS around sleep hygiene, blow up the medical gaslighting around “disorders,” and dig into how a former aspiring butterfly became one of the loudest voices for patient-centered science. Also: naps, kids, burnout, CPAPs, co-sleeping, airport pods, the DeLorean, and Carl Sagan. If you think you're getting by on five hours of sleep and vibes, you're not. This episode will make you want to take a nap—and then call your doctor.RELATED LINKSdammgoodsleep.com: https://www.dammgoodsleep.comLinkedIn: https://www.linkedin.com/in/anne-marie-morse-753b2821/Instagram: https://www.instagram.com/dammgoodsleepDocWire News Author Page: https://www.docwirenews.com/author/anne-marie-morseSleep Review Interview: https://sleepreviewmag.com/practice-management/marketing/word-of-mouth/sleep-advocacy-anne-marie-morse/Geisinger Bio: https://providers.geisinger.org/provider/anne-marie-morse/756868SWHR Profile: https://swhr.org/team/anne-marie-morse-do-faasm/FEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Check out the TIES Sales Showdown at www.tx.ag/TIESVisit The Sales Lab at https://thesaleslab.org and check out all our guests' recommended readings at https://thesaleslab.org/reading-listTo listen to The Sales Lab Podcast on your favorite apps, visit https://thesaleslab.simplecast.com/ and select your preferred method of listening.Connect with us on Facebook at https://www.facebook.com/saleslabpodcastConnect with us on Linkedin at https://www.linkedin.com/company/thesaleslabSubscribe to The Sales Lab channel on YouTube at  https://www.youtube.com/channel/UCp703YWbD3-KO73NXUTBI-Q 

This week, Lynnsey and Lauren are joined by Maynard Nexsen attorney Jennifer McEwen, who helps clients with business planning, estate and trust planning, and tax planning. Jennifer shares essential business strategies for physicians and life sciences entrepreneurs, from succession planning and shareholder agreements to navigating ownership restrictions and tax-smart business structures. Whether you're launching a healthcare or life sciences startup or preparing for retirement as a provider, Jennifer and Lauren offer actionable insights to help protect your business and your legacy. Tune in now!

In this episode, we explore how TileDB, an innovative data system originally developed at MIT and Intel Labs, is revolutionizing healthcare and life sciences data management. We'll dive deep into how TileDB's universal data engine efficiently handles complex scientific data - from genomic sequences to medical imaging - in a unified format, and learn how healthcare organizations can leverage TileDB on AWS to accelerate research, improve collaboration, and reduce infrastructure costs. Join host AWS Solutions Architect for HCLS Gokhul Srinivasan and guest Devika Garg form TileDB as they discuss real-world applications in precision medicine, genomic analysis, and how TileDB is transforming the way healthcare providers manage and analyze patient data.To Learn More:https://www.tiledb.com/AWS Hosts: Nolan Chen & Gokhul SrinivasanEmail Your Feedback: rethinkpodcast@amazon.com

In January, 1997, David Nierenberg was a physician at Dartmouth‐Hitchcock Medical Center, specializing in toxicology. Chemist Karen Wetterhahn was placed in his care. When she arrived at the hospital, Karen was slurring her speech and having difficulty balancing and with coordination. What David soon learned was that her symptoms were all due to a few tiny drops of a compound called dimethylmercury. Today's episode focuses on two lab accidents that had a profound impact on research communities, and that inspired changes that have likely saved the lives of scientists and other workers since. The first story is that of Karen Wetterhahn who, in the 1990s was a professor of chemistry at Dartmouth College whose lab focused on heavy metal toxicity. The other story is about fatal prion protein exposures in France that led to a temporary moratorium in 2021. Send us your science facts, news, or other stories for a chance to be featured on an upcoming Tiny Show and Tell Us bonus episode. And, while you're at it, subscribe to our newsletter!Links to the Tiny Show and Tell stories are here and here. All Tiny Matters transcripts and references are available here.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

July 9, 2025: Todd Barton, AVP, Enterprise Sales Engineering at Rubrik, and PV SubbaRao, SVP of Global Healthcare and Life Sciences from Rackspace, reveal how they're revolutionizing healthcare's approach to cyber resilience through their groundbreaking partnership. The conversation delves deep into the concept of Isolated Recovery Environments (IRE) and the "Minimum Viable Hospital" - but what exactly does it mean to operate at bare minimum while maintaining patient care, and how do you determine what systems are truly essential when every second counts? As healthcare organizations grapple with doing more with less, these experts explore how proper cyber recovery planning can actually unlock 20-25% cost savings that can be reinvested into the innovations hospitals need.  Key Points: 05:04 Preemptive Recovery  10:21 Minimum Viable Hospital and IRE 20:21 Cost and Productivity Optimization X: This Week Health LinkedIn: This Week Health Donate: Alex's Lemonade Stand: Foundation for Childhood Cancer

Gigi Robinson grew up with Ehlers-Danlos syndrome, a disease that turns your joints into overcooked spaghetti. Instead of letting it sideline her, she built a career out of telling the truth about invisible illness. We talk about what it takes to grow up faster than you should, why chronic illness is the worst unpaid internship, and how she turned her story into a business. You'll hear about her days schlepping to physical therapy before sunrise, documenting the sterile absurdity of waiting rooms, and finding purpose in the mess. Gigi's not interested in pity or polished narratives. She wants you to see what resilience really looks like, even when it's ugly. If you think you know what an influencer does, think again. This conversation will challenge your assumptions about work, health, and what it means to be seen.RELATED LINKSGigi Robinson Website: https://www.gigirobinson.comLinkedIn: https://www.linkedin.com/in/gigirobinsonInstagram: https://www.instagram.com/itsgigirobinsonTikTok: @itsgigirobinsonA Kids Book About Chronic Illness: https://akidsco.com/products/a-kids-book-about-chronic-illnessFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Daniel Castner, AIA, LEED AP is Principal and Director of the Life Science practice at Mancini Duffy where he is passionate about workplace strategy with a focus on research labs, medical space, and anything requiring a helpful orchestrator of AEC coordination. Mike Petrusky asks Dan about his experiences helping the IFMA community, the importance of client relationships and the use of technology in workplace strategy. They explore design trends and emphasize the core elements of flexibility and being intentional when delivering spaces that meet the needs of the workforce. Dan believes that change management has evolved to focus more on the employee experience and wellbeing, rather than just specific projects, so using sensors and analytics can help leaders understand human priorities. Dan's unique experience in life science workplaces have led him to focus on building a culture of collaboration and innovation, so he shares some encouragement, practical advice and the inspiration you will need to be a Workplace Innovator! Take the Eptura™ Podcast Survey: https://forms.office.com/r/jY577CbNcx Connect with Dan on LinkedIn: https://www.linkedin.com/in/danielcastner/ Learn more about Mancini Duffy: https://www.manciniduffy.com/ Discover free resources and explore past interviews at: https://www.workplaceinnovator.com/ Learn more about Eptura™: https://eptura.com/ Connect with Mike on LinkedIn: https://www.linkedin.com/in/mikepetrusky/  

In this insightful interview with Blue Box Asset Mangement's Porfolio Manager Mark Dainty we talk about precision medicine and life sciences, his investment strategy, and how he constructs a portfolio of "developers" vs "enablers". We also talk about 3 stocks in the fund. We hope you enjoy listening!  *~*~*~*~*  Get access to all of Speedwell Research's in-depth Research Reports here. If you need help getting Speedwell added as an approved research vendor for your investment firm, please reach out to info@speedwellresearch.com  -*-*-*-*-*-*-*-*-*-*- Show Notes (0:00) — What is Precision Medicine and Life Sciences (11:15) — Small Markets, but Higher Prices (22:24) — Why Precision Medicine is like Dating Apps (27:56) — Investment Strategy and Portfolio Construction (47:20) — Two Stocks: Natera ($NTRA) and Guardant Health ($GH) (54:24) — Risk of the Unknown? (1:02:55) — Revolutions Medicines ($RVMD) (1:11:10) — Financial Modeling -*-*-*-*-*-*-*-*-*-*- Become a Speedwell Member here to gain access to *all* of our in-depth research reports and more!   Sign up for Speedwell's free newsletter and weekly memos here *~*~*~*~*  Follow Us: Twitter: @Speedwell_LLC Threads: @speedwell_research Email us at info@speedwellresearch.com for any questions, comments, or feedback. -*-*-*-*-*-*-*-*-*-*- Disclaimer Nothing in this podcast is investment advice nor should be construed as such. Contributors to the podcast may own securities discussed. Furthermore, accounts contributors advise on may also have positions in companies discussed. Please see our full disclaimers here:  https://speedwellresearch.com/disclaimer/

Episode Description:If you've ever wondered what happens when a Bronx-born pediatric nurse with stage 4 colon cancer survives, raises a kid, becomes a policy shark, and fights like hell for the ignored, meet Vanessa Ghigliotty. She's not inspirational. She's a bulldozer. We go way back—like pre-Stupid Cancer back—when there was no “young adult cancer movement,” just a handful of pissed-off survivors building something out of nothing. This episode is personal. Vanessa and I built the plane while flying it. She fought to be heard, showed up in chemo dragging her kid to IEP meetings, and never stopped screaming for the rest of us to get what we needed. We talk war stories, progress, side-eyeing advocacy fads, TikTok activism, gatekeeping, policy wins, and why being loud is still necessary. And yeah—she's a damn good mom. Probably a better one than you. You'll laugh. You'll cry. You'll want to scream into a pillow. Come for the nostalgia. Stay for the righteous anger and iced coffee.RELATED LINKSVanessa on LinkedInColorectal Cancer Alliance: Vanessa's StoryZenOnco Interview with VanessaFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

What if the next virus isn't natural, but deliberately engineered and used as a weapon? As geopolitical tensions rise and biological threats become more complex, health security and life sciences are emerging as critical pillars of national defense.In the special edition episode from our new series, “The Ripple Effect: Investing in Life Sciences”, host Dan Riskin is joined by two leading voices at the intersection of biotechnology and defense: Dawn Meyerriecks, former CIA Deputy Director for Science and Technology and current member of the National Security Commission on Emerging Biotechnology, and Jason Kelly, co-founder and CEO of Ginkgo Bioworks. Together, they explore the dual-use nature of biotechnology and the urgent need for international oversight, genetic attribution standards, and robust viral surveillance. From pandemic preparedness and fragile supply chains to AI-driven lab automation and airport biosurveillance, their conversation highlights how life science innovation strengthens national resilience and strategic defense.This timely conversation follows the June 25th, 2025 Hague Summit Declaration, where NATO allies pledged to invest 5% of GDP in defense by 2035—including up to 1.5% on resilience and innovation to safeguard critical infrastructure, civil preparedness, networks, and the defense industrial base. This limited series, produced by GZERO's Blue Circle Studios in partnership with Novartis, examines how life science innovation plays a vital role in fulfilling that commitment. Subscribe to “The Ripple Effect: Investing in Life Sciences” series on your preferred podcast platform.Look for the next episode of the GZERO World with Ian Bremmer podcast when we kick off our eighth season on July 5, 2025.Host: Dan RiskinGuests: Jason Kelly, Dawn Meyerriecks Subscribe to the GZERO World with Ian Bremmer Podcast on Apple Podcasts, Spotify, or your preferred podcast platform, to receive new episodes as soon as they're published.